This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1999 Feb;66(2):256.

doi: 10.1136/jnnp.66.2.256.

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F] dopa PET

PMID: 10071122
PMCID: PMC1736231
DOI: 10.1136/jnnp.66.2.256

Comment

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F] dopa PET

R J Hardie. J Neurol Neurosurg Psychiatry. 1999 Feb.

. 1999 Feb;66(2):256.

doi: 10.1136/jnnp.66.2.256.

Author

PMID: 10071122
PMCID: PMC1736231
DOI: 10.1136/jnnp.66.2.256

No abstract available

PubMed Disclaimer

Comment on

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.
Morrish PK, Rakshi JS, Bailey DL, Sawle GV, Brooks DJ. Morrish PK, et al. J Neurol Neurosurg Psychiatry. 1998 Mar;64(3):314-9. doi: 10.1136/jnnp.64.3.314. J Neurol Neurosurg Psychiatry. 1998. PMID: 9527140 Free PMC article.

Similar articles

Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.
Morrish PK, Rakshi JS, Bailey DL, Sawle GV, Brooks DJ. Morrish PK, et al. J Neurol Neurosurg Psychiatry. 1998 Mar;64(3):314-9. doi: 10.1136/jnnp.64.3.314. J Neurol Neurosurg Psychiatry. 1998. PMID: 9527140 Free PMC article.
Clinical and [18F] dopa PET findings in early Parkinson's disease.
Morrish PK, Sawle GV, Brooks DJ. Morrish PK, et al. J Neurol Neurosurg Psychiatry. 1995 Dec;59(6):597-600. doi: 10.1136/jnnp.59.6.597. J Neurol Neurosurg Psychiatry. 1995. PMID: 7500096 Free PMC article.
An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease.
Morrish PK, Sawle GV, Brooks DJ. Morrish PK, et al. Brain. 1996 Apr;119 ( Pt 2):585-91. doi: 10.1093/brain/119.2.585. Brain. 1996. PMID: 8800950
Advances in imaging Parkinson's disease.
Brooks DJ. Brooks DJ. Curr Opin Neurol. 1997 Aug;10(4):327-31. doi: 10.1097/00019052-199708000-00008. Curr Opin Neurol. 1997. PMID: 9266157 Review.
[PET study using 6-[18F]-fluorodopa in Parkinson's disease].
Nagasawa H, Tanji H, Itoh M, Itoyama Y. Nagasawa H, et al. Nihon Rinsho. 1997 Jan;55(1):213-7. Nihon Rinsho. 1997. PMID: 9014452 Review. Japanese.

See all similar articles

Cited by

Dopamine transporter SPECT using fast kinetic ligands: 123I-FP-beta-CIT versus 99mTc-TRODAT-1.
Van Laere K, De Ceuninck L, Dom R, Van den Eynden J, Vanbilloen H, Cleynhens J, Dupont P, Bormans G, Verbruggen A, Mortelmans L. Van Laere K, et al. Eur J Nucl Med Mol Imaging. 2004 Aug;31(8):1119-27. doi: 10.1007/s00259-004-1480-6. Epub 2004 Apr 3. Eur J Nucl Med Mol Imaging. 2004. PMID: 15064872 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information